Matches in Nanopublications for { ?s ?p "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP545059.RAmoKqaDvMoGUC_QeIa-94QCHfiqVROTgI8bEnGyZhHUw130_assertion description "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545059.RAmoKqaDvMoGUC_QeIa-94QCHfiqVROTgI8bEnGyZhHUw130_provenance.
- NP337396.RAKMYK8lqmnVj6Fh8i-2_RycjWgzr8lMLvmBKINgE5jME130_assertion description "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337396.RAKMYK8lqmnVj6Fh8i-2_RycjWgzr8lMLvmBKINgE5jME130_provenance.
- NP450128.RARcpXwQm6kiFDjPSw_aTeoBWYNnBBb1QWB7Q8wQebohs130_assertion description "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450128.RARcpXwQm6kiFDjPSw_aTeoBWYNnBBb1QWB7Q8wQebohs130_provenance.
- NP939974.RA68O3SELKVNj0nWT02j-e6lXPACPdso4hRLba3D7u1Vw130_assertion description "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939974.RA68O3SELKVNj0nWT02j-e6lXPACPdso4hRLba3D7u1Vw130_provenance.
- NP1004382.RAHwMItt4D2hEwpS29us9kXuyRBb3odehjdRDYI-GPo8M130_assertion description "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004382.RAHwMItt4D2hEwpS29us9kXuyRBb3odehjdRDYI-GPo8M130_provenance.
- NP939975.RAmeq1C2NpIaJKqbUUMllD0DUPoXVxM46gDEjvhD6kJxA130_assertion description "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939975.RAmeq1C2NpIaJKqbUUMllD0DUPoXVxM46gDEjvhD6kJxA130_provenance.
- NP957453.RALuTCBhi8Lm4dNvd7Dy7ntJTssrVWXSlOM6YML8Im0wU130_assertion description "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957453.RALuTCBhi8Lm4dNvd7Dy7ntJTssrVWXSlOM6YML8Im0wU130_provenance.
- NP939973.RAGRL5Osxe3Nb76trbJQ9IdYZtRB1IErvHyrQaHul6l40130_assertion description "[Metastatic tumour antigen 1 (MTA1) promotes angiogenesis by stabilizing hypoxia-inducible factor-1α (HIF-1α), which is closely associated with frequent postoperative recurrence and poor survival in patients with HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939973.RAGRL5Osxe3Nb76trbJQ9IdYZtRB1IErvHyrQaHul6l40130_provenance.